Howard Hughes Medical Institute’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
VCM
VPM
Howard Hughes Medical Institute's ORCL Position: Q1 2026 in Review
Howard Hughes Medical Institute increased its Oracle (ORCL) stake by 6,525% in Q1 2026, buying an estimated $3.82M and bringing the position to 23,851 shares worth $3.51M. The position accounts for 0.84% of the portfolio, ranked #19.
Howard Hughes Medical Institute first reported a position in ORCL in Q2 2014 and has held it in 6 quarters since. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.
- Howard Hughes Medical Institute held 23,851 shares of Oracle worth $3.51M as of Q1 2026.
- Howard Hughes Medical Institute bought 23,491 Oracle shares in Q1 2026, an estimated $3.82M.
- Oracle made up 0.84% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #19 holding.
- Howard Hughes Medical Institute first reported a position in Oracle in Q2 2014 and has held it in 6 quarters since.
- 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.
Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.